Literature DB >> 25744335

Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.

Joo Youn Shin1, Moonjung Choi1, Byunghoon Chung1, Suk Ho Byeon2.   

Abstract

PURPOSE: The purpose of the study was to compare the rates and characteristics of retinal pigment epithelial (RPE) tears between typical exudative age-related macular degeneration (tAMD) and polypoidal choroidal vasculopathy (PCV) after injection of intravitreal ranibizumab (IVR).
METHODS: In total, 836 eyes from 784 patients with exudative AMD treated with IVR were analyzed. The presence, type, size, and height of pigment epithelial detachment (PED) in OCT before injection were evaluated, and the occurrence rate of RPE tears within three months of injection between tAMD and PCV was compared.
RESULTS: In total, 515 eyes (61.6 %) had tAMD and 321 eyes (38.4 %) were diagnosed as PCV. RPE tears developed in 18 eyes (3.5 %) in the tAMD group, while only two eyes (0.62 %) were associated with PCV (p = 0.009, Chi-square test). Eleven of the eighteen eyes with RPE tears in tAMD had fibrovascular PED with contractile neovascular tissue under the surface of the RPE and a cleft at baseline. Two eyes with RPE tears in PCV showed large hemorrhagic PED before presenting with an RPE tear.
CONCLUSIONS: RPE tears after IVR were significantly less common in PCV than in tAMD. The different characteristics of RPE tears between the two disease entities suggest differences in the pathogenesis underlying the event.

Entities:  

Keywords:  Age-related macular degeneration; Anti-vascular endothelial growth factor; Polypoidal choroidal vasculopathy; Ranibizumab; Retinal pigment epithelial tear

Mesh:

Substances:

Year:  2015        PMID: 25744335     DOI: 10.1007/s00417-015-2977-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  40 in total

1.  Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy.

Authors:  H Iijima; M Imai; T Gohdo; S Tsukahara
Journal:  Am J Ophthalmol       Date:  1999-03       Impact factor: 5.258

2.  Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy.

Authors:  Masami Nakajima; Mitsuko Yuzawa; Hiroyuki Shimada; Ryusaburo Mori
Journal:  Jpn J Ophthalmol       Date:  2004 May-Jun       Impact factor: 2.447

3.  Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study.

Authors:  M Leitritz; F Gelisken; W Inhoffen; M Voelker; F Ziemssen
Journal:  Eye (Lond)       Date:  2008-06-06       Impact factor: 3.775

4.  Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.

Authors:  Clement K Chan; Prema Abraham; Carsten H Meyer; Gregg T Kokame; Peter K Kaiser; Michael E Rauser; Jeffrey G Gross; Asha S D Nuthi; Steven G Lin; Noha S Daher
Journal:  Retina       Date:  2010-02       Impact factor: 4.256

5.  Pathogenesis of tears of the retinal pigment epithelium.

Authors:  J D Gass
Journal:  Br J Ophthalmol       Date:  1984-08       Impact factor: 4.638

6.  Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature.

Authors:  C H Meyer; C A Toth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-06       Impact factor: 3.117

7.  Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation.

Authors:  H Terasaki; Y Miyake; T Suzuki; M Nakamura; T Nagasaka
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

8.  Clinicopathologic findings in polypoidal choroidal vasculopathy.

Authors:  Hiroyuki Nakashizuka; Masako Mitsumata; Shigekuni Okisaka; Hiroyuki Shimada; Akiyuki Kawamura; Ryusaburo Mori; Mitsuko Yuzawa
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-27       Impact factor: 4.799

Review 9.  Polypoidal choroidal vasculopathy and treatments.

Authors:  Fumi Gomi; Yasuo Tano
Journal:  Curr Opin Ophthalmol       Date:  2008-05       Impact factor: 3.761

10.  RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised PED secondary to AMD.

Authors:  Maria Andreea Gamulescu; Carsten Framme; Helmut Sachs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-21       Impact factor: 3.535

View more
  1 in total

Review 1.  Polypoidal choroidal vasculopathy: An update on current management and review of literature.

Authors:  Amit Harishchandra Palkar; Vikas Khetan
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.